Estimation of tumor proliferative activity according to expression of cell-cycle-related antigen and selection of fractionation schema in radiation therapy.
Estimation of tumor proliferative activity according to expression of cell-cycle-related antigen and selection of fractionation schema in radiation therapy.
批准号:
08671025
负责人:
NISHIMURA Yasumasa
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have performed various basic and clinical studies on tumor proliferation and radiation therapy,1)To understand better the repopulation kinetics of tumor cells after radiotherapy (RT), we investigated changes in cell proliferative parameters after single-dose irradiation of murine tumors. As one of conclusions, recruitment of previously quiescent cells into the proliferative pool in the tumors was suggested to contribute to repopulation after RT.(ref.2)2)Combined effects of an antiangiogenic agent (TNP-470) with fractionated RT were investigated using a murine tumor. The tumor control probability decreased by administrating TPN-470 during fractionated RT in air. This unexpected result may be contributable to partial inhibition of reoxygenation by TNP-470, because no significant changes in TCD-50 under hypoxic conditions by TNP-470. (ref.6)3)The effects of overall treatment time (OTT) on local control of RT were evaluated to consider optimal OTT in RT.Local control rates and acute and … More late toxicities of esophageal cancer, glottic cancer, and uterine cervical cancer were analyzed. In the multivariate analysis, OTT was a significant prognostic factor for local control. In conclusion, OTT should be kept as short as Possible wiyhin the limits of tolerance of normal tissues and patients. (ref.4)4)The relationship of immunohistochemical indices of proliferating cell nuclear antigen (PCNA) and Ki-67 to local control and survival rates for patients with esophageal squamous cell carcinomas treated by definitive radiotherapy (RT) was investigated. Biopsy materials before RT were obtained from 65 patients with esophageal cancer. The PCNA LI was independent of known prognostic factors on local control for esophageal cancer. Patients with the PCNA LI of<50% or the Ki-67 LI of<45% showed significantly higher local recurrence rates than those with higher LIs (p<0.05). In conclusion, PCNA LI and Ki-67 LI were significantly correlated with local control probabilities in esophageal. squamous cell carcinomas treated by definitive RT.PCNA LI may be a useful parameter for selecting the fractionation scheme of esophageal cancers. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nishimura Y.,et.al.: "Optimal overall treatment time in fractionated radiotherapy for head and neck cancers,esophageal cancer,and uterine cervical cancer." J.Jpn.Soc.Ther.Radiol.Oncol.8. 303‐315 (1996)
Nishimura Y.,et.al.:“头颈癌、食道癌和宫颈癌分次放射治疗的最佳总体治疗时间。”J.Jpn.Soc.Ther.Radiol.Oncol.8。 1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishimura Y., et al: "Optimal overall treatment time in fractionated radiotherapy for head and neck cancere,esophageal cancer and uterine cervical cancer." J.Jpn.Soc.Ther.Radiol.Oncol.8. 303-315 (1996)
Nishimura Y.等人:“头颈癌、食道癌和宫颈癌分段放射治疗的最佳总体治疗时间。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shibamoto Y,Ohshio G,Hosotani R,Nishimura Y,Manabe T,Imamura M,Abe M.: "A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy." Br J Cancer. 76. 1474-1479 (1997)
Shibamoto Y、Ohshio G、Hosotani R、Nishimura Y、Manabe T、Imamura M、Abe M.:“缺氧细胞放射增敏剂 KU-2285 与术中放疗相结合的 I/II 期研究。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shibamoto Y., Nishimura Y., Tsutsui K., Sasai K., Takahashi M., Abe M.: "Cmparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma." Jpn.J.Clin Oncol. 27. 31-36 (1997)
Shibamoto Y.、Nishimura Y.、Ttsutsui K.、Sasai K.、Takahashi M.、Abe M.:“加速超分割放射治疗和常规放射治疗幕上恶性胶质瘤的比较。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shibamoto Y., Nishimura Y., 他: "A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy" Br.J.Cancer. 76. 1474-1479 (1997)
Shibamoto Y.、Nishimura Y. 等人:“低氧细胞放射增敏剂 KU-2285 与术中放疗联合的 I/II 期研究”Br.J.Cancer 76. 1474-1479 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Organ-specific tolerance doses in intensity-modulated radiation therapy for head and neck cancer
-
批准号:20K08009
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:NISHIMURA Yasumasa
-
依托单位:
Adaptive radiation therapy based on in-room CT image
-
批准号:16K10406
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2016
-
负责人:NISHIMURA Yasumasa
-
依托单位:
High precision radiation therapy based on intra-tumoral hypoxic imaging
-
批准号:25461932
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:NISHIMURA Yasumasa
-
依托单位:
Development of the next generation radiation therapy based on molecular imaging
-
批准号:22591392
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:NISHIMURA Yasumasa
-
依托单位:
Clinical studies on the simultaneous integrated boost method using intensity modulated radiotherapy (IMRT)
-
批准号:17591300
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2005
-
负责人:NISHIMURA Yasumasa
-
依托单位:
Development of intensity modulated radiation therapy (IMRT) based on radiobiology
-
批准号:14570887
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2002
-
负责人:NISHIMURA Yasumasa
-
依托单位:
Relationship between molecular pathology of tumors and radiobiological parameters
-
批准号:11670921
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:NISHIMURA Yasumasa
-
依托单位:
海外基金